{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:31Z","timestamp":1792785031484,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sichuan Medical Youth Innovation Research Project","award":["Q23014"],"award-info":[{"award-number":["Q23014"]}]},{"name":"Suining Health Science and Technology Project","award":["24CJDFB07"],"award-info":[{"award-number":["24CJDFB07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-86061-4","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:20:29Z","timestamp":1736918429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Bioinformatic analysis of ferroptosis related biomarkers and potential therapeutic targets in vitiligo"],"prefix":"10.1038","volume":"15","author":[{"given":"Linli","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunshui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"86061_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1159\/000506103","volume":"236","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist, C., Ezzedine, K. & Vitiligo Rev. Dermatology 236, 571\u2013592 (2020).","journal-title":"Rev. Dermatology"},{"key":"86061_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jamadermatol.2021.4724","volume":"158","author":"K Gandhi","year":"2022","unstructured":"Gandhi, K. et al. Prevalence of Vitiligo among adults in the United States. JAMA Dermatol. 158, 43\u201350 (2022).","journal-title":"JAMA Dermatol."},{"key":"86061_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000528180","volume":"239","author":"R Patel","year":"2023","unstructured":"Patel, R. et al. Prevalence of Vitiligo among children and adolescents in the United States. Dermatology 239, 227\u2013234 (2023).","journal-title":"Dermatology"},{"key":"86061_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/ced\/llad028","volume":"48","author":"H Kang","year":"2023","unstructured":"Kang, H. & Lee, S. Prevalence and incidence of vitiligo and associated comorbidities: a nationwide population-based study in Korea. Clin. Exp. Dermatol. 48, 484\u2013489 (2023).","journal-title":"Clin. Exp. Dermatol."},{"key":"86061_CR5","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1111\/jdv.18257","volume":"36","author":"K Bibeau","year":"2022","unstructured":"Bibeau, K. et al. Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA. J. Eur. Acad. Dermatol. Venereol. 36, 1831\u20131844 (2022).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"86061_CR6","doi-asserted-by":"publisher","first-page":"9749","DOI":"10.3390\/ijms24119749","volume":"24","author":"T Iwanowski","year":"2023","unstructured":"Iwanowski, T., Ko\u0142kowski, K., Nowicki, R. J. & Soko\u0142owska-Wojdy\u0142o, M. Etiopathogenesis and emerging methods for treatment of Vitiligo. Int. J. Mol. Sci. 24, 9749 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"86061_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/dna.2023.0188","volume":"43","author":"LY Liu","year":"2024","unstructured":"Liu, L. Y. et al. The role of regulatory cell Death in Vitiligo. DNA Cell. Biol. 43, 61\u201373 (2024).","journal-title":"DNA Cell. Biol."},{"issue":"6","key":"86061_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon, S. J. & Olzmann, J. A. The cell biology of ferroptosis. Nat. Rev. Mol. Cell. Biol. 25 (6), 424\u2013442 (2024).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"86061_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/pcmr.13032","volume":"35","author":"X Wu","year":"2022","unstructured":"Wu, X. et al. Altered expression of ferroptosis markers and iron metabolism reveals a potential role of ferroptosis in vitiligo. Pigment Cell. Melanoma Res. 35, 328\u2013341 (2022).","journal-title":"Pigment Cell. Melanoma Res."},{"key":"86061_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12967-022-03566-6","volume":"20","author":"D Zhang","year":"2022","unstructured":"Zhang, D. et al. Evidence of pyroptosis and ferroptosis extensively involved in autoimmune diseases at the single-cell transcriptome level. J. Transl Med. 20, 363 (2022).","journal-title":"J. Transl Med."},{"key":"86061_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12864-024-10147-y","volume":"25","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Identification and validation of RNA-binding protein SLC3A2 regulates melanocyte ferroptosis in vitiligo by integrated analysis of single-cell and bulk RNA-sequencing. BMC Genom. 25, 236 (2024).","journal-title":"BMC Genom."},{"key":"86061_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbrc.2021.05.010","volume":"561","author":"M Yang","year":"2021","unstructured":"Yang, M. et al. Baicalein inhibits RLS3-induced ferroptosis in melanocytes. Biochem. Biophys. Res. Commun. 561, 65\u201372 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"86061_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/pcmr.13101","volume":"36","author":"NF Post","year":"2023","unstructured":"Post, N. F. et al. Trained immunity in the pathogenesis of vitiligo. Pigment Cell. Melanoma Res. 36, 348\u2013354 (2023).","journal-title":"Pigment Cell. Melanoma Res."},{"key":"86061_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12016-022-08956-8","volume":"63","author":"F Gibson","year":"2022","unstructured":"Gibson, F. et al. Epigenetic dysregulation in autoimmune and inflammatory skin diseases. Clin. Rev. Allergy Immunol. 63, 447\u2013471 (2022).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"86061_CR15","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell, B. R. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185, 2401\u20132421 (2022).","journal-title":"Cell"},{"key":"86061_CR16","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/med.21754","volume":"41","author":"J Chen","year":"2021","unstructured":"Chen, J., Li, S. & Li, C. Mechanisms of melanocyte death in vitiligo. Med. Res. Rev. 41, 1138\u20131166 (2021).","journal-title":"Med. Res. Rev."},{"key":"86061_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2022.01.012","volume":"180","author":"GH Chen","year":"2022","unstructured":"Chen, G. H. et al. Mitochondrial oxidative stress mediated Fe-induced ferroptosis via the NRF2-ARE pathway. Free Radic Biol. Med. 180, 95\u2013107 (2022).","journal-title":"Free Radic Biol. Med."},{"key":"86061_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jdermsci.2023.04.006","volume":"110","author":"CY Ng","year":"2023","unstructured":"Ng, C. Y. et al. Targeting the elevated IFN-\u03b3 in vitiligo patients by human anti- IFN-\u03b3 monoclonal antibody hampers direct cytotoxicity in melanocyte. J. Dermatol. Sci. 110, 78\u201388 (2023).","journal-title":"J. Dermatol. Sci."},{"key":"86061_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/ced.12464","volume":"40","author":"P Li","year":"2015","unstructured":"Li, P., Ma, H., Han, D. & Mou, K. Interleukin-33 affects cytokine production by keratinocytes in vitiligo. Clin. Exp. Dermatol. 40, 163\u2013170 (2015).","journal-title":"Clin. Exp. Dermatol."},{"key":"86061_CR20","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.cell.2015.08.021","volume":"162","author":"N Arpaia","year":"2015","unstructured":"Arpaia, N. et al. A distinct function of regulatory T Cells in tissue protection. Cell 162, 1078\u20131089 (2015).","journal-title":"Cell"},{"key":"86061_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00403-016-1675-2","volume":"308","author":"M Vaccaro","year":"2016","unstructured":"Vaccaro, M. et al. IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo. Arch. Dermatol. Res. 308, 527\u2013530 (2016).","journal-title":"Arch. Dermatol. Res."},{"key":"86061_CR22","doi-asserted-by":"crossref","unstructured":"Rachinger, N. et al. Alpha-Synuclein and Its Role in Melanocytes. Cells. 11, 2087 (2022).","DOI":"10.3390\/cells11132087"},{"key":"86061_CR23","doi-asserted-by":"publisher","first-page":"e23287","DOI":"10.1096\/fj.202301489R","volume":"37","author":"E Niederberger","year":"2023","unstructured":"Niederberger, E. et al. Distinct molecular mechanisms contribute to the reduction of melanoma growth and tumor pain after systemic and local depletion of alpha-synuclein in mice. FASEB J. 37, e23287 (2023).","journal-title":"FASEB J."},{"key":"86061_CR24","doi-asserted-by":"publisher","first-page":"9243","DOI":"10.1038\/s41598-023-36451-3","volume":"13","author":"N Gajendran","year":"2023","unstructured":"Gajendran, N., Rajasekaran, S. & Witt, S. N. Knocking out alpha-synuclein in melanoma cells downregulates L1CAM and decreases motility. Sci. Rep. 13, 9243 (2023).","journal-title":"Sci. Rep."},{"key":"86061_CR25","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1038\/s41598-021-84443-y","volume":"11","author":"S Shekoohi","year":"2021","unstructured":"Shekoohi, S. et al. Knocking out alpha-synuclein in melanoma cells dysregulates cellular iron metabolism and suppresses tumor growth. Sci. Rep. 11, 5267 (2021).","journal-title":"Sci. Rep."},{"key":"86061_CR26","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1177\/24725552211030288","volume":"26","author":"M Scalise","year":"2021","unstructured":"Scalise, M. et al. ASCT1 and ASCT2: brother and sister? SLAS Discov. 26, 1148\u20131163 (2021).","journal-title":"SLAS Discov"},{"key":"86061_CR27","doi-asserted-by":"publisher","first-page":"1228199","DOI":"10.3389\/fonc.2023.1228199","volume":"13","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Ferroptosis regulator NOS2 is closely associated with the prognosis and cell malignant behaviors of hepatoblastoma: a bioinformatic and in vitro study. Front. Oncol. 13, 1228199 (2023).","journal-title":"Front. Oncol."},{"key":"86061_CR28","doi-asserted-by":"publisher","first-page":"6423","DOI":"10.2147\/IJGM.S327348","volume":"14","author":"N Zeng","year":"2021","unstructured":"Zeng, N. et al. Construction of a Ferroptosis-related gene signature for predicting survival and immune microenvironment in melanoma patients. Int. J. Gen. Med. 14, 6423\u20136438 (2021).","journal-title":"Int. J. Gen. Med."},{"key":"86061_CR29","doi-asserted-by":"publisher","first-page":"115554","DOI":"10.1016\/j.bcp.2023.115554","volume":"212","author":"M Wang","year":"2023","unstructured":"Wang, M. et al. ALOX5 promotes autophagy-dependent ferroptosis by activating the AMPK\/mTOR pathway in melanoma. Biochem. Pharmacol. 212, 115554 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"86061_CR30","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/jid.2011.463","volume":"132","author":"JE Harris","year":"2012","unstructured":"Harris, J. E. et al. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8\u207a T-cell accumulation in the skin. J. Invest. Dermatol. 132, 1869\u20131876 (2012).","journal-title":"J. Invest. Dermatol."},{"key":"86061_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/1346-8138.15743","volume":"48","author":"C Bergqvist","year":"2021","unstructured":"Bergqvist, C., Ezzedine, K. & Vitiligo A focus on pathogenesis and its therapeutic implications. J. Dermatol. 48, 252\u2013270 (2021).","journal-title":"J. Dermatol."},{"key":"86061_CR32","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jaad.2016.12.021","volume":"76","author":"JP Strassner","year":"2017","unstructured":"Strassner, J. P., Rashighi, M., Ahmed Refat, M., Richmond, J. M. & Harris, J. E. Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity. J. Am. Acad. Dermatol. 76, 847\u2013855 (2017).","journal-title":"J. Am. Acad. Dermatol."},{"key":"86061_CR33","doi-asserted-by":"publisher","first-page":"110505","DOI":"10.1016\/j.intimp.2023.110505","volume":"121","author":"WM Hu","year":"2023","unstructured":"Hu, W. M. et al. The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK\/STAT and inhibits pancreatic cancer invasion and metastasis. Int. Immunopharmacol. 121, 110505 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"86061_CR34","doi-asserted-by":"publisher","first-page":"105947","DOI":"10.1016\/j.intimp.2019.105947","volume":"78","author":"CH Liu","year":"2020","unstructured":"Liu, C. H. et al. Zileuton ameliorates depressive-like behaviors, hippocampal neuroinflammation, apoptosis and synapse dysfunction in mice exposed to chronic mild stress. Int. Immunopharmacol. 78, 105947 (2020).","journal-title":"Int. Immunopharmacol."},{"issue":"Suppl 1","key":"86061_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/bjd.13639","volume":"172","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis, C. C. & Bettoli, V. Management of severe acne. Br. J. Dermatol. 172 (Suppl 1), 27\u201336 (2015).","journal-title":"Br. J. Dermatol."},{"key":"86061_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijwd.2020.01.009","volume":"6","author":"S Mushtaq","year":"2020","unstructured":"Mushtaq, S. & Sarkar, R. Sulfasalazine in dermatology: a lesser explored drug with broad therapeutic potential. Int. J. Womens Dermatol. 6, 191\u2013198 (2020).","journal-title":"Int. J. Womens Dermatol."},{"key":"86061_CR37","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1080\/13685538.2020.1806814","volume":"23","author":"E Karag\u00fcn","year":"2020","unstructured":"Karag\u00fcn, E. & Baysak, S. Levels of TNF-\u03b1, IL-6, IL-17, IL-37 cytokines in patients with active vitiligo. Aging Male. 23, 1487\u20131492 (2020).","journal-title":"Aging Male"},{"key":"86061_CR38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.4103\/0378-6323.45103","volume":"74","author":"S Aghaei","year":"2008","unstructured":"Aghaei, S. An uncontrolled, open label study of sulfasalazine in severe Alopecia Areata. Indian J. Dermatol. Venereol. Leprol. 74, 611\u2013613 (2008).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"86061_CR39","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.3390\/ijms25084409","volume":"25","author":"HL Yamaguchi","year":"2024","unstructured":"Yamaguchi, H. L., Yamaguchi, Y. & Peeva, E. Pathogenesis of Alopecia Areata and Vitiligo: commonalities and differences. Int. J. Mol. Sci. 25, 4409 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"86061_CR40","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.jid.2017.06.012","volume":"137","author":"VS Spiegelman","year":"2017","unstructured":"Spiegelman, V. S., Elcheva, I. A. & Metabo-miR miR-211 regulates mitochondrial energy metabolism in Vitiligo. J. Invest. Dermatol. 137, 1828\u20131830 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"86061_CR41","doi-asserted-by":"publisher","first-page":"13526","DOI":"10.1038\/s41598-022-17770-3","volume":"12","author":"HY Abdallah","year":"2022","unstructured":"Abdallah, H. Y. et al. Investigating melanogenesis-related microRNAs as disease biomarkers in vitiligo. Sci. Rep. 12, 13526 (2022).","journal-title":"Sci. Rep."},{"key":"86061_CR42","doi-asserted-by":"publisher","first-page":"111615","DOI":"10.1016\/j.yexcr.2019.111615","volume":"384","author":"M Su","year":"2019","unstructured":"Su, M. et al. miR-9 regulates melanocytes adhesion and migration during vitiligo repigmentation induced by UVB treatment. Exp. Cell. Res. 384, 111615 (2019).","journal-title":"Exp. Cell. Res."},{"key":"86061_CR43","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/bjd.19666","volume":"184","author":"HD Brahmbhatt","year":"2021","unstructured":"Brahmbhatt, H. D. et al. The long noncoding RNA MALAT1 suppresses miR-211 to confer protection from ultraviolet-mediated DNA damage in vitiligo epidermis by upregulating sirtuin 1. Br. J. Dermatol. 184, 1132\u20131142 (2021).","journal-title":"Br. J. Dermatol."},{"key":"86061_CR44","doi-asserted-by":"crossref","unstructured":"Lai, N. S., Yu, H. C., Huang, H. B., Huang Tseng, H. Y. & Lu, M. C. Increased Expression of Long Noncoding RNA LOC100506314 in T cells from Patients with Nonsegmental Vitiligo and Its Contribution to Vitiligo Pathogenesis. Mediators Inflamm. 2440377 (2023). (2023).","DOI":"10.1155\/2023\/2440377"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86061-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86061-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86061-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:54:05Z","timestamp":1736920445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86061-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86061"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86061-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study was approved by the Ethics Committee of Suining Central Hospital and written consents from the patients were obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"2035"}}